Top Markets
#1 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +33.55%
#2 Bitcoin Cash Bitcoin Cash +33.37%
#3 Audiera Audiera +31.77%
#4 Fabric Protocol Fabric Protocol +30.62%
#5 Tutorial Tutorial +28.68%
#6 GALA GALA +28.51%
#7 TROLL TROLL +28.24%
#8 Arowana Arowana +27.65%
#9 Useless Coin Useless Coin +26.71%
#10 Ethena Staked ENA Ethena Staked ENA +26.37%
Coin of the day
Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Rang in Aktien #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Aktienkurs
$0.95011029
Zuletzt synchronisiert: 2023-06-28
Marktkapitalisierung
$57.72M
Veränderung (1 Tag)
8.53%
Veränderung (1 Jahr)
0.00%
Land
FR
Handel ERYTECH Pharma S.A. (ERYP)

Kategorie

Healthcare
Kursverlauf für ERYTECH Pharma S.A. (ERYP)
Höchster Schlusskurs: $0.90 am 2023-06-01

Niedrigster Schlusskurs: $14.08 am 2013-05-01
Kursverlauf der Aktie von ERYTECH Pharma S.A. von 2013 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.19 38.17%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 58.07%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.12 464.91%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 9.84%
CH